Accenture Vested, grant-date fair value remained flat by 0.0% to $474.83M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $431.59M to $474.83M. Over 4 years (FY 2021 to FY 2025), Vested, grant-date fair value shows an upward trend with a 13.2% CAGR.
An increase reflects higher total compensation costs and potential future dilution for existing shareholders.
The total grant-date fair value of all equity instruments that vested during the reporting period. This figure represent...
Widely reported by public companies to disclose the magnitude of equity-based compensation.
other_share_based_compensation_arrangement_by_share_base_dbbe07| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.16B | $1.34B | $1.72B | $1.73B | $1.90B |
| YoY Change | — | +16.2% | +27.8% | +0.6% | +10.0% |